Is vaginal estrogen safe?

Low-dose vaginal estrogen is often lumped in with systemic HRT, but the experts treat it as a genuinely distinct, lower-risk option. It's a local therapy — a cream, ring, or tablet — used for the genitourinary syndrome of menopause (GSM): vaginal dryness, painful sex, and recurrent urinary tract infections. Because the dose is low and the delivery is local, systemic absorption is minimal, so it doesn't carry the same considerations as systemic estrogen.

Attia covers this most directly with urologist Dr. Rachel Rubin, who emphasizes that vaginal estrogen is safe, cheap, effective, and badly under-used — and that recurrent UTIs in older women are frequently a treatable consequence of GSM rather than something to manage with repeated antibiotics. Via Dr. Mary Claire Haver, Huberman treats low-dose vaginal estrogen for genitourinary symptoms as a low-risk, minimal-absorption use case, separate from the systemic HRT conversation.

The practical upshot: a woman who isn't a candidate for — or doesn't want — systemic hormone therapy may still be a candidate for vaginal estrogen to address local symptoms. The FDA's November 2025 labeling action covered topical vaginal estrogen products as well as systemic ones.

The caveat is the same as everywhere in this topic: "minimal systemic absorption" is reassuring but not a blanket clearance. Women with a personal history of hormone-sensitive cancer should make this decision with their oncologist and a menopause specialist, not from an article.